🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Spain / NCT07451587
Starting soon Not applicable

Personalized Care Management Model (GAP-421) for Chronic Pain in Primary Care Physiotherapy

NCT07451587 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2026-09
Last updated
2026-03-05

Condition(s) studied

Chronic PainChronic Non-cancer PainCare CoordinationPrimary Health CareMusculoskeletal Pain

Investigational drug(s) / intervention(s)

GAP-421 Personalized Care Management Model

GAP-421 Personalized Care Management Model: It reorganizes existing resources through a 6-week window: Phase 1 - Activation (Day 0): The lead physiotherapist identifies 2 or more organizational mismatch signals. Documented in a standardized GAP Activation Form. Phase 2 - Characterization (Week 1): Comprehensive assessment in protected time slot (45-60 min). Establishment of shared clinical message across professionals. Phase 3 - Coordinated Intervention (Weeks 2-4): Therapeutic education, graded exercise, pharmacological adjustment if indicated Phase 4 - Closure (Weeks 4-6): Semi-annual plan with milestones, de-escalation criteria. Return to standard Service 421 circuit Key organizational features: The physiotherapist becomes the primary process manager for the chronic pain episode.

Study summary

This multicenter pilot study evaluates the feasibility, implementation fidelity, and preliminary effects of the GAP-421 (Personalized Care Management) model for chronic pain management in primary care physiotherapy. The GAP model is a time-limited organizational modality that reconfigures schedules, resources, and professional roles during a defined 6-week window to organize care around the individual patient and their trajectory, formalizing coordination work that previously occurred informally.

The study uses a convergent mixed-methods design across three primary care health centers in the Southeast Healthcare District (DASE) of the Community of Madrid, Spain. The quantitative component is a prospective multicenter pre-post case series with 3-month follow-up (n=66 patients, 22 per center). The qualitative component includes semi-structured interviews (n=12) and focus groups (3 groups, n=6 each). Integration occurs through Joint Display, Pillar Integration Process, and a 9-type legitimation framework.

The primary outcome is patient-perceived care coordination measured on a 0-10 numerical scale (PREM). Secondary outcomes span five domains: patient-reported outcomes (EQ-5D-5L, Graded Chronic Pain Scale, pain intensity), professional outcomes (coordination burden, role clarity), system sustainability (avoidable re-consultations, emergency department use), implementation fidelity, and feasibility indicators.

Results will generate feasibility parameters, intraclass correlation coefficient estimates, and process indicators essential for designing definitive cluster-randomized trials testing organizational interventions in primary care physiotherapy.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adults aged 18 years or older * Enrolled in Service 421 of the Madrid Primary Care Service Portfolio (chronic non-cancer pain of at least 3 months duration) * Pain intensity NRS of 4 or higher in the last 2 weeks OR functional limitation score of 2 or higher (Annex 54, SERMAS Service Portfolio) * Ability to understand and sign informed consent * Ability to complete study questionnaires in Spanish Exclusion Criteria: * Active cancer pain * Documented moderate-to-severe cognitive disorder (ICD-10 diagnosis or registered functional assessment) * Decompensated psychiatric disorder that, in the clinical judgment of the physiotherapist and/or family physician, interferes with study participation * Immediate clinical emergency at enrollment * Simultaneous participation in another clinical trial or organizational intervention study * Anticipated inability to complete 3-month follow-up (planned relocation, imminent institutionalization) * Explicit refusal to participate

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
CS Valleaguado Coslada Madrid
Centro de Salud Buenos Aires - Physiotherapy Unit Madrid Madrid

More Universidad Autonoma de Madrid trials in Spain

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07451587 on ClinicalTrials.gov ↗ ← All trials in Spain